Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -910.14% is in line with its 5-year average of -969.74%, near the high end of its 5-year range (-186566.67%–67.43%).
23.15% above its 12-month average of -1184.23%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -622.84%.
NET PROFIT MARGIN
-910.14%
NET PROFIT MARGIN AVG TTM
-1184.23%
NET PROFIT MARGIN AVG 3Y
-960.62%
NET PROFIT MARGIN AVG 5Y
-969.74%
NET PROFIT MARGIN AVG 10Y
-609.14%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+23.15%
CURRENT VS 3Y AVG
+5.25%
CURRENT VS 5Y AVG
+6.15%
CURRENT VS 10Y AVG
-49.41%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-259940.00%
vs the sector median at left
Sol-Gel Technologies Ltd.
Market Cap
$247.27M
Net Profit Margin
-910.14%
TTM Avg
-1184.23%
3Y Avg
-960.62%
5Y Avg
-969.74%
Market Cap
$247.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$248.50M
Net Profit Margin
-2543.74%
TTM Avg
-5120.97%
3Y Avg
-6084.02%
5Y Avg
-4060.63%
Market Cap
$249.79M
Net Profit Margin
-4955.67%
TTM Avg
-3838.03%
3Y Avg
-2627.07%
5Y Avg
-2627.07%
Market Cap
$241.94M
Net Profit Margin
N/A
TTM Avg
-26.91%
3Y Avg
-35.21%
5Y Avg
-46.29%
Market Cap
$241.39M
Net Profit Margin
62.87%
TTM Avg
27.75%
3Y Avg
54.97%
5Y Avg
-757.17%
Market Cap
$241.34M
Net Profit Margin
-6138.26%
TTM Avg
-3731.55%
3Y Avg
-4082.97%
5Y Avg
-2721.98%
Market Cap
$239.02M
Net Profit Margin
-8.78%
TTM Avg
-964.82%
3Y Avg
-2640.79%
5Y Avg
-1760.53%
Market Cap
$239.01M
Net Profit Margin
-4.52%
TTM Avg
-4.68%
3Y Avg
-9.38%
5Y Avg
-10.81%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sol-Gel Technologies Ltd. (SLGL) | $247.27M | -910.14% | -1184.23% | -960.62% | -969.74% |
| Galectin Therapeutics Inc. (GALT)vs › | $247.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $248.50M | -2543.74% | -5120.97% | -6084.02% | -4060.63% |
| Upstream Bio, Inc. (UPB)vs › | $249.79M | -4955.67% | -3838.03% | -2627.07% | -2627.07% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | -26.91% | -35.21% | -46.29% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 62.87% | 27.75% | 54.97% | -757.17% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | -6138.26% | -3731.55% | -4082.97% | -2721.98% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | -8.78% | -964.82% | -2640.79% | -1760.53% |
| High Tide Inc. (HITI)vs › | $239.01M | -4.52% | -4.68% | -9.38% | -10.81% |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | -3.14% | -28.33% | -34.54% | -25.62% |
Operating Margin
-38.9%
Net Profit Margin
-910.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -622.84% |
| 2026-03-31 | -3450.93% |
| 2025-12-31 | -429.17% |
| 2025-09-30 | -1485.50% |
| 2025-06-30 | 67.26% |
| 2025-03-31 | -854.32% |
| 2024-12-31 | -2102.88% |
| 2024-09-30 | -6.83% |
| 2024-06-30 | 36.37% |
| 2024-03-31 | -1361.37% |
| 2023-12-31 | -1081.88% |
| 2023-09-30 | -2681.22% |
| 2023-06-30 | -1005.05% |
| 2023-03-31 | -1353.96% |
| 2022-12-31 | -5785.00% |
| 2022-09-30 | -1305.36% |
| 2022-06-30 | -3.81% |
| 2022-03-31 | -186566.67% |
| 2021-12-31 | 67.43% |
| 2021-09-30 | 14.55% |
| 2021-06-30 | -865.62% |
| 2021-03-31 | -579.60% |
| 2020-12-31 | -315.41% |
| 2020-09-30 | -407.37% |
| 2020-06-30 | -624.01% |
| 2020-03-31 | -205.19% |
| 2019-12-31 | -164.23% |
| 2019-09-30 | -155.36% |
| 2019-06-30 | -63.21% |
| 2019-03-31 | -90.09% |
| 2018-12-31 | 593800.00% |
| 2018-09-30 | -20281.58% |
| 2018-06-30 | -14095.92% |
| 2018-03-31 | -12984.09% |
| 2017-12-31 | -3132.18% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
